Localized dystrophic epidermolysis bullosa, acral form

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:158673Q81.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Localized dystrophic epidermolysis bullosa, acral form (also known as acral dystrophic epidermolysis bullosa or dystrophic EB, pretibial type in some classifications) is a rare inherited skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) spectrum. It is caused by mutations in the COL7A1 gene, which encodes type VII collagen — a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in blistering and skin erosions predominantly affecting the acral (distal extremity) areas such as the hands and feet. Clinically, this form of DEB is characterized by mechanically induced blisters, erosions, and scarring that are largely confined to the hands, feet, and sometimes the nails. Nail dystrophy is a common feature, and milia (small white cysts) may develop at sites of healed blisters. Unlike more severe generalized forms of dystrophic epidermolysis bullosa, the acral form tends to have a milder course with limited skin involvement and generally does not affect mucosal surfaces or internal organs to a significant degree. However, repeated trauma to the extremities can lead to progressive scarring and functional impairment over time. There is currently no cure for localized dystrophic epidermolysis bullosa, acral form. Management is primarily supportive and focuses on wound care, prevention of trauma and infection, and protection of vulnerable skin areas. Careful bandaging, use of padded footwear, and avoidance of friction are important preventive strategies. Wound infections should be treated promptly with appropriate antibiotics. Genetic counseling is recommended for affected individuals and their families. Research into gene therapy, protein replacement therapy, and other molecular approaches for dystrophic EB is ongoing but has not yet yielded approved treatments specific to this subtype.

Also known as:

Clinical phenotype terms— hover any for plain English:

TelangiectasiaHP:0001009PoikilodermaHP:0001029Dystrophic toenailHP:0001810Esophageal strictureHP:0002043Crusting erythematous dermatitisHP:0007473Dystrophic fingernailsHP:0008391Acral blisteringHP:0031045Recurrent loss of toenails and fingernailsHP:0008390Abnormality of the elbowHP:0009811
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Localized dystrophic epidermolysis bullosa, acral form.

View clinical trials →

No actively recruiting trials found for Localized dystrophic epidermolysis bullosa, acral form at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Localized dystrophic epidermolysis bullosa, acral form community →

No specialists are currently listed for Localized dystrophic epidermolysis bullosa, acral form.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Localized dystrophic epidermolysis bullosa, acral form.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Localized dystrophic epidermolysis bullosa, acral formForum →

No community posts yet. Be the first to share your experience with Localized dystrophic epidermolysis bullosa, acral form.

Start the conversation →

Latest news about Localized dystrophic epidermolysis bullosa, acral form

No recent news articles for Localized dystrophic epidermolysis bullosa, acral form.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Localized dystrophic epidermolysis bullosa, acral form

What is Localized dystrophic epidermolysis bullosa, acral form?

Localized dystrophic epidermolysis bullosa, acral form (also known as acral dystrophic epidermolysis bullosa or dystrophic EB, pretibial type in some classifications) is a rare inherited skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) spectrum. It is caused by mutations in the COL7A1 gene, which encodes type VII collagen — a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in blistering and skin erosions

At what age does Localized dystrophic epidermolysis bullosa, acral form typically begin?

Typical onset of Localized dystrophic epidermolysis bullosa, acral form is neonatal. Age of onset can vary across affected individuals.